Astellas’ Hot Flash Drug Veozah Slapped With Another FDA Warning for Liver Injury

One patient developed elevated liver blood tests after receiving Astellas Pharma’s non-hormonal small molecule blocker, leading the regulator to add a warning to the drug’s label.